Obesity: Will withaferin win the war?

Nature Medicine

Volumn 22, Issue 9, 2016, Pages 970-971

  Pfluger, Paul T ^a   Tschöp, Matthias H ^a,b  

^a GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CELASTROL; GLUCOSE; INSULIN; LEPTIN; WITHAFERIN A; WITHANOLIDE;

ANTIDIABETIC ACTIVITY; DIABETES MELLITUS; DIET INDUCED OBESITY; DRUG MEGADOSE; ENDOPLASMIC RETICULUM STRESS; FAT MASS; FATTY LIVER; FOOD INTAKE; GLUCOSE TOLERANCE; HORMONE SENSITIVITY; HUMAN; INSULIN SENSITIVITY; LOW DRUG DOSE; NONHUMAN; NOTE; OBESITY; PRIORITY JOURNAL; WEIGHT CONTROL; WEIGHT REDUCTION;

HUMANS; OBESITY; WITHANOLIDES;

EID: 84986247411     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4182     Document Type: Note

References (10)

1. Tschöp, M.H. et al. Cell Metab. 24, 51-62 (2016).
2. Lee, J. et al. Nat. Med. 22, 1023-1032 (2016).
3. Liu, J., Lee, J., Salazar Hernandez, M.A., Mazitschek, R. & Ozcan, U. Cell 161, 999-1011 (2015).
4. Myers, M.G. Jr. et al. Cell Metab. 15, 150-156 (2012).
5. Kim, J.E. et al. PLoS One 8, e62068 (2013).
6. McKenna, M.K. et al. Cancer Biol. Ther. 16, 1088-1098 (2015).
7. Yang, H. & Dou, Q.P. Curr. Drug Targets 11, 733-744 (2010).
8. Kleinridders, A. et al. J. Clin. Invest. 123, 4667-4680 (2013).
9. Zhang, X. et al. Cell 135, 61-73 (2008).
10. Ma, X. et al. Cell Metab. 22, 695-708 (2015).